Skip to search formSkip to main contentSkip to account menu

Atazanavir 50 MG Oral Powder [Reyataz]

Known as: ATAZANAVIR SULFATE 50 mg ORAL POWDER [REYATAZ], Reyataz 50 MG Oral Powder, Reyataz 50 MG per packet Oral Powder 
National Institutes of Health

Related topics

Related topics

6 relations
AspartameAtazanavirAtazanavir sulfateOral Powder

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Identification and structural elucidation of in vitro metabolites of atazanavir by HPLC and tandem mass spectrometry.
Atazanavir (marketed as Reyataz®) is an important member of the human immunodeficiency virus protease inhibitor class. LC-UV-MS(n… 
2012
2012
Unboosted Atazanavir for Treatment of HIV Infection
Atazanavir (Reyataz®) is a protease inhibitor (PI) for the treatment of HIV infection. Several trials have demonstrated the good… 
Review
2004
Review
2004
Additional antiretroviral and immunosuppressive drug-drug interactions.
To the Editor: As appropriately pointed out in the review article by Izzedine et al1, cyclosporine, tacrolimus, and sirolimus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)